tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Novartis announces CHMP of EMA adopted positive opinion for Fabhalta
The FlyNovartis announces CHMP of EMA adopted positive opinion for Fabhalta
4d ago
NVS
Novartis holder Emasan selling 26.5M shares, Bloomberg reports
PremiumThe Fly
Novartis holder Emasan selling 26.5M shares, Bloomberg reports
7d ago
NVS
Emasan files to sell 26.5M shares of Novartis, Bloomberg reports
PremiumThe Fly
Emasan files to sell 26.5M shares of Novartis, Bloomberg reports
7d ago
NVS
Novartis’ Ianalumab granted FDA orphan designation
PremiumThe Fly
Novartis’ Ianalumab granted FDA orphan designation
19d ago
NVS
Novartis downgraded to Neutral from Buy at UBS
PremiumThe Fly
Novartis downgraded to Neutral from Buy at UBS
19d ago
NVS
Novartis initiated with an Underweight at Morgan Stanley
PremiumThe FlyNovartis initiated with an Underweight at Morgan Stanley
20d ago
NVS
Novartis agrees to acquire Anthos for up to $3.1B
Premium
The Fly
Novartis agrees to acquire Anthos for up to $3.1B
21d ago
BX
NVS
Hold Rating for Novartis AG Due to Limited Potential of Abelacimab Despite Acquisition of Anthos Therapeutics
Premium
Ratings
Hold Rating for Novartis AG Due to Limited Potential of Abelacimab Despite Acquisition of Anthos Therapeutics
21d ago
NVS
Trump Trade: President advocates to close carried interest tax loophole
PremiumThe Fly
Trump Trade: President advocates to close carried interest tax loophole
25d ago
X
BX
White House readying order to fire thousands of federal health workers, WSJ says
PremiumThe Fly
White House readying order to fire thousands of federal health workers, WSJ says
26d ago
CI
AZN
Novartis CEO discusses search for obesity deals with WSJ
PremiumThe Fly
Novartis CEO discusses search for obesity deals with WSJ
28d ago
NVS
TERN
Novartis upgraded to Buy from Hold at Deutsche Bank
PremiumThe Fly
Novartis upgraded to Buy from Hold at Deutsche Bank
28d ago
NVS
Novartis price target raised to CHF 90 from CHF 85 at Barclays
PremiumThe FlyNovartis price target raised to CHF 90 from CHF 85 at Barclays
29d ago
NVS
Novartis AG Earnings Call Highlights Strong Growth and Strategic Challenges
Premium
Company Announcements
Novartis AG Earnings Call Highlights Strong Growth and Strategic Challenges
1M ago
NVS
Navigating Risks: Novartis’s Strategic Challenges in Expanding Innovative Medicines Portfolio
Premium
Company Announcements
Navigating Risks: Novartis’s Strategic Challenges in Expanding Innovative Medicines Portfolio
1M ago
NVS
Novartis AG Reports Strong Sales Growth and Innovation
PremiumCompany Announcements
Novartis AG Reports Strong Sales Growth and Innovation
1M ago
NVS
Ionis ‘remains confident in pelacarsen’ after Novartis update on Phase 3 timing
PremiumThe Fly
Ionis ‘remains confident in pelacarsen’ after Novartis update on Phase 3 timing
1M ago
NVS
IONS
Morning Movers: Apple and Exxon higher following quarterly earnings
PremiumThe Fly
Morning Movers: Apple and Exxon higher following quarterly earnings
1M ago
V
CL
Novartis Releases 2024 Annual and Integrated Reports
PremiumCompany Announcements
Novartis Releases 2024 Annual and Integrated Reports
1M ago
6K
NVS
Novartis Reports Strong 2024 Financial Performance and Innovation Milestones
PremiumCompany AnnouncementsNovartis Reports Strong 2024 Financial Performance and Innovation Milestones
1M ago
6K
NVS
Novartis reports Q4 core EPS $1.98 vs. $1.53 last year
Premium
The Fly
Novartis reports Q4 core EPS $1.98 vs. $1.53 last year
1M ago
NVS
Novartis proposes 6.1% dividend increase to CHF 3.50 per share for 2024
Premium
The Fly
Novartis proposes 6.1% dividend increase to CHF 3.50 per share for 2024
1M ago
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >